
Roxie Nafousi's New Book Redefines Confidence In The Digital Age
Far from the brash self-assurance that dominates social media, true confidence speaks in much lower tones, notes Roxie Nafousi. 'It's quiet, grounded, and rooted in self-respect,' says the self-development coach, Podcast show host and bestselling author, whose latest work, Confidence: 8 Steps to Knowing Your Worth, releases today on March 27. Offering an antidote to the comparison-driven digital landscape where self-doubt flourishes, Nafousi's new book is set to redefine the way confidence is perceived and practiced in the internet age.
Perhaps not always the most obvious person to author a book on building confidence, Nafousi says she didn't always embody that unwavering belief. 'I was suffering with low self-esteem from 7 years old,' she reveals. 'I distinctly remember picking myself apart, feeling less than and like an outsider based on the way I looked and my Iraqi heritage.' But it's this early struggle and her subsequently formed self-acceptance and authenticity that laid the foundation of what would eventually become her life's work.
Studies estimate that over 4.9 billion people worldwide scroll through various social media feeds on a daily basis, with digital platforms now becoming the breeding rounds for what experts call 'scroll-induced insecurity.' It's reported that the average person spends 2.5 hours daily on these platforms, with 16-24 year olds exceeding 3 hours — time largely spent absorbing carefully curated images that can potentially trigger harmful comparison.
For adolescents, the stakes are even higher. Research published in JAMA Psychiatry found those spending more than 3 hours daily on social media faced double the risk of anxiety and depression. As a result, the UK's Royal College of Psychiatrists labeled social media-induced low self-esteem as 'one of the most significant and under-addressed public health concerns of our time.'
Aspirational exhaustion — a term referring to the state where one's sense of self becomes increasingly fragile against impossible standards, is the inevitable outcome of consuming constant stream of filtered lives. For a generation whose confidence has been eroded by the validation-seeking cycle of likes, shares, and followers, this environment makes Nafousi's message about internal validation particularly relevant.
Instead of overwhelming her audience with generic 'confidence tips' that seem to have flooded the wellness space, Nafousi's approach differentiates by placing an emphasis on authenticity. 'People connect through authenticity and vulnerability,' she explains. Her framework moves beyond superficial advice, addressing the root causes of insecurity while offering practical tools for lasting change.
Roxie Nafousi's new book, Confidence: 8 Steps To Knowing Your Worth, releases today on March 27
Amongst other functional solutions, one powerful concept she introduces in the book is the recognition of 'cognitive distortions' — or what she calls 'thought filters' — which are patterns of thinking that distort reality and reinforce self-doubt. 'Becoming aware of these distortions helps you pause, zoom out, and ask: Is this thought really true or is it based on my past experiences, limiting beliefs and current state of mind?'
For Nafousi, who has been candid from day one about her personal struggles that inspired her bestselling Manifest series, confidence isn't about perfection but rather 'being at peace with who you are — not because you're perfect, but because you've stopped trying to be.'
Through her own experience, Nafousi discovered that confidence isn't built overnight but through consistent, intentional practices. In a recent article she has written for British Vogue, the author shares five simple changes that transformed her relationship with herself: visualization, improving posture, accepting compliments without deflection, dressing as her best self, and carefully choosing who she spends time with.
Perhaps most surprising to readers is her emphasis on turning outward rather than inward. In her book, she emphasizes 'being of service to others' as a confidence builder, which seems counterintuitive to those who think confidence comes from self-focus. 'One of the most powerful and unexpected confidence boosters is actually looking outward and being of service to others,' she explains. 'When we help others, we're reminded of our value in a deeply meaningful way.'
The book comes at a time when the pursuit of external validation intensifies as a result of social media. For many, especially women navigating societal expectations, relationship between physical appearance and inner confidence can be a delicate yet complex topic.
Nafousi encourages her flowers to step into the multi-faceted beings they are, sharing on her Instagram: 'The professional, the mother, the sexy — they all deserve space to shine.'
'There's no denying that how we look can impact how we feel — but for women especially, the relationship between appearance and confidence is layered and often shaped by societal pressure,' she says. Her solution isn't to ignore these realities but to 'reclaim the narrative' by strengthening internal validation systems that can withstand external judgment. 'Part of confidence is stepping into your power and owning all the different sides of you,' Nafousi shares in her recent Instagram post, encouraging her followers to step into the multi-faceted beings they are. Always open about her own journey and progress, followers of Nafousi can see her gradually stepping into her most authentic self over the years — the author has been open on matters from her choices in style and beauty to view on business investments. 'The professional, the mother, the sexy — they all deserve space to shine,' says Nafousi.
For those struggling with imposter syndrome or feeling confident in private but insecure in public, the book offers practical advice like body language adjustments, breathwork, and gradual exposure to uncomfortable situations.
As the line between healthy self-improvement and harmful perfectionism continues to blur, the book's message provides a timely recalibration. Nafousi's eight-step framework offers a roadmap not just to feeling better about oneself, but to fundamentally shifting how one shows up in the world.
'True confidence,' the author says, 'isn't built in a day; it's built in the quiet choices we make every day to honor ourselves, even when no one is watching.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
8 hours ago
- Newsweek
Veterans Urge Trump to Declassify Documents About Gulf War Syndrome
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A veterans group has called on President Donald Trump's administration to declassify documents related to the first Gulf War, Newsweek can exclusively reveal. In a letter sent to the Department of Defense on February 18, 2025, and seen by Newsweek, Vietnam Veterans of America (VVA) urged the DOD to make public all documents related to the 1990-1991 conflict in case they hold evidence that could assist researchers in treating veterans who remain ill because of exposure to toxic substances. They raised particular concerns about information about the demolition of an Iraqi ammunition storage site at Khamisiyah in March 1991, which led to the release of chemicals into the atmosphere. The DOD replied to the letter, advising the group to contact the National Archives and Records Administration (NARA). A DOD official told Newsweek: "The health of Department of Defense (DOD) personnel and veterans remains a high priority to the DOD. Representatives from the DOD Office of the Assistant Secretary of Defense for Health Affairs have been in correspondence with, and recently met with, representatives from the Vietnam Veterans of America (VVA) to discuss topics associated with findings on demolitions involving Iraqi chemical weapons at Khamisiyah, Iraq in 1991." "The DOD is committed to providing up-to-date health risk communications to DoD personnel and veterans," the official said. "Similarly, the DOD works closely with the Department of Veterans Affairs (VA) to coordinate and collaborate, as needed, to help facilitate veterans' access to all appropriate care and benefits available to them. As such, the DOD supports efforts by veterans to take full advantage of VA health care and benefits, including any new or updated provisions of the Sergeant First Class (SFC) Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act." Newsweek reached out to NARA via email for comment. Gulf War veterans attend the groundbreaking ceremony for the National Desert Storm and Desert Storm Memorial in Washington, D.C., on July 14, 2022. Gulf War veterans attend the groundbreaking ceremony for the National Desert Storm and Desert Storm Memorial in Washington, D.C., on July 14, 2022. AP Photo/Gemunu Amarasinghe Gulf War Illness (GWI), also known as Gulf War Syndrome, is a disease that affects up to one in three veterans who served in the Gulf War, a conflict sparked in response to Iraq's annexation of Kuwait. During the war, military personnel were exposed to chemical and biological warfare, which led to unexplained symptoms including rashes, diarrhea, muscle pain, cognitive issues, reduced coordination and fatigue. The DOD concluded that about 100,000 Gulf War veterans could have been exposed to low levels of nerve agents from Khamisiyah, specifically. Over the years, GWI has perplexed scientists worldwide, who have conducted numerous studies in an effort to treat it. In 2024, scientists from Griffith University in Australia identified a faulty cell function that could be linked to the illness. While this was considered a research breakthrough, veterans are still facing barriers in receiving adequate treatment and advocacy groups say more research is needed to understand the condition fully. In its letter, VVA said it was "writing to formally request the declassification of all records, documents, and materials" concerning the Gulf War. "The significance of this matter cannot be overstated, as it directly impacts veterans, their families, researchers, and the public's right to understand the events and potential exposures that occurred," the letter said. "The release of these records would serve the interests of transparency, accountability, and public trust, providing crucial information for ongoing health studies and care for those affected." The group also asked the DOD to issue a letter to veterans warning them that they may have been exposed to toxic substances. In response, Tracie Lattimore, the acting deputy assistant secretary at the DOD's Health Readiness Policy and Oversight team, said in a May 2025 letter seen by Newsweek that in 2019, the department had submitted all classified materials from 1940 to 2021 to NARA and advised the group to contact the agency. "My team and I are eager to continue discussions" about deployment-related exposure, said Lattimore. She added that the DOD is continuing "to investigate potential deployment-related exposures." Sgt. 1st Class Carol Picou holds a photo of a Gulf War bombing site in Kuwait during a press conference in Washington, D.C., on May 6, 1997, where she called for an independent inquiry into... Sgt. 1st Class Carol Picou holds a photo of a Gulf War bombing site in Kuwait during a press conference in Washington, D.C., on May 6, 1997, where she called for an independent inquiry into the health and environmental consequences of the war. More AP Photo/Ron Edmonds The DOD official also told Newsweek: "Based on continued concerns voiced about the potential negative long-term health effects of exposures at Khamisiyah, the DOD is currently in the process of investigating whether any updates to the original letters are warranted based on newly incorporated data, recent research findings, and any other new considerations that could impact the original findings or recommendations to those who were possibly affected." The VVA told Newsweek that it hoped that the release of documents regarding the assassinations of Attorney General Robert F. Kennedy and President John F. Kennedy, which Trump ordered upon his return to the White House, would persuade the administration to declassify other documents. "We have no idea of what's inside these documents as they have never been seen outside of the DOD community," Ronald Brown, a toxic wounds consultant at VVA, told Newsweek. "Could they hold evidence that could assist researchers in finding treatment for these sick veterans? It's possible, but they could also offer nothing. However, we feel in the order of transparency that these documents should be released and added to the site the DOD established on the Gulf War back in 1997, so it can act as a permanent repository for everything related to the first Gulf War for future generations to have access to," Brown said. Meanwhile, as advocacy groups wrangle to get answers, GWI continues to plague veterans. Alan Sigmon, a 53-year-old veteran who served from August 2, 1989, to August 2, 1993, and suffers from GWI, decided to serve in the U.S. Army because he saw it as "a very patriotic thing to do." "My great-grandfathers served in nearly every American war," Sigmon told Newsweek. "Some paid the ultimate price. My father was military. I joined the Army and deployed to the Gulf because I believed in duty, in service, and in the promise that this country would stand by us." During his deployment, Sigmon said he was "very scared" and often "couldn't sleep." "I was very close to the front lines, I could see the shelling, smell the smoke. It was like a sight out of hell," Sigmon told Newsweek. Because of frequent explosions, "our tent would glow orange at night," he said. Nevertheless, Sigmon said he wanted to support his country. But his service has been repaid with unexplained skin rashes and burning headaches, which he began experiencing in 2005. "My head would become hot to the touch, and the pain made me physically ill," he said. "After that came the dizziness, crushing fatigue, GI dysfunction, nerve pain, numb extremities, muscle spasms, insomnia, and memory loss. I was falling apart, and no one could tell me why." In December 2023, Sigmon applied for a clinical trial led by the University of Alabama at Birmingham and funded primarily by the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP). While UAB initially told him that he was eligible for the study, he was ultimately disqualified in February 2024 due to a post-traumatic stress disorder diagnosis. A spokesperson for UAB told Newsweek veterans with PTSD had been excluded from the trial because they are separate conditions with overlapping symptoms, and that including them could cause the study to "fail." They added that it was important to "ensure that study results are scientifically relevant and ultimately help veterans." "Involving participants with ongoing, severe PTSD can damage the proper interpretation of study data and invalidate findings regarding GWI," they said. Sigmon and other veterans now feel left behind because of a lack of adequate research into the condition. In 2006, Congress began redirecting GWI research funding into the CDMRP, a process that continued until 2022, when it was integrated into the broader Toxic Exposure Research Program (TERP) within the CDMRP. The FY25 defense appropriations bill slashed overall CDMRP funding by 57 percent, and TERP funding was halved. "I gave everything and laid my life on the line when my country asked me. Now I am struggling to survive and the very people and Government institutions have coldly turned their backs on me like I am the problem," Sigmon told Newsweek. "I feel like the government has forgotten about us." Donald Overton, the executive director for the Blinded Veterans Association, told Newsweek he still has "flare-ups" of chronic fatigue after being exposed to toxins in the region while serving from 1988 to 1993. He believes that GWI sufferers are a "group that has really been lost in the shuffle" and that more research should be done to support them. "We just don't want to be forgotten," Overton said. Beatrice Golomb, a professor of medicine at the University of California, San Diego School of Medicine, who has researched GWI, said veterans will "continue to suffer." Releasing and developing "more information" would help support veterans, she told Newsweek. "A sizable fraction of Gulf War veterans (GWV) (~1/4 to ~1/3) developed chronic multisymptom health problems attributed to Gulf-related exposures, and these problems have not diminished with time," Golomb said. "Moreover, GWV and especially those with GWI have shown elevated rates of a very large number of additional health problems." "Veterans continue to suffer and more information would benefit not only the veterans but—our data and others data suggest—individuals who experience other toxic and mixed toxic chemical exposures and indeed the population overall is increasingly exposed to chemical mixtures, albeit serially across the lifetime, so what we learn to help GWV may be of help to us all," she said. In an effort to ensure veterans are not forgotten, the group Veterans for Common Sense has called on Congress to restore a dedicated medical research program for GWI and expand outreach to ill Gulf War veterans to inform them about research and treatment opportunities. Anthony Hardie, the director of Veterans for Common Sense, told Newsweek: "As many as one-third of the veterans of the 1990-91 Gulf War continue to suffer from GWI, and potentially other veterans and future veterans with similar military toxic exposures. Restoring Gulf War Illness research funding is critical, with a clear research pipeline aimed at treatments and prevention. No one should be cutting that funding before finishing the job developing effective GWI treatments. We should not be abandoning these veterans who are still suffering, mostly in silence." A spokesperson for the Department of Veterans Affairs told Newsweek that the VA has been conducting research on the health of Gulf War veterans for nearly 30 years and has offered access to multiple care streams to manage symptoms related to GWI. A CDMRP spokesperson told Newsweek that the agency was continuing its research into GWI. "All CDMRP programs, including the TERP, utilize CDMRP's two-tiered review process to fund research of high merit that addresses program goals and aligns with congressional intent," the spokesperson said. "During the second tier of review, the TERP's programmatic panel uses multiple criteria to make funding recommendations, and 'program portfolio composition and balance' is one of these criteria. During the FY24 application review cycle Gulf War Illness and Its Treatment had the highest percentage of applications recommended for funding (22.7 percent) among the FY24 TERP topic areas."
Yahoo
10-07-2025
- Yahoo
Antidepressant withdrawal is rare, study finds. Here are the most common symptoms
Going off of antidepressants may not come with as many side effects as people think, an extensive new analysis has found. The study, published in the journal JAMA Psychiatry, is the largest review to date on antidepressant withdrawal symptoms, according to the researchers from the United Kingdom. It sought to understand what happens when people stop taking antidepressants, and to identify which symptoms come from discontinuing medication and which could reflect a potential relapse of depression or other mental health issues. 'Our work finds that most people do not experience severe withdrawal, in terms of additional symptoms,' Dr Sameer Jauhar, the study's lead author and a researcher at Imperial College London, said in a statement. The review included 50 randomised controlled trials – which are considered the gold standard in medical research – spanning about 17,800 people. On average, people who stopped taking antidepressants experienced symptoms such as dizziness, nausea, vertigo, and nervousness in the first two weeks. But most people had few enough symptoms that they were considered 'below the cutoff' for clinical withdrawal, the study found. People's moods also did not appear to get worse as a result of discontinuing their medicine, meaning it could instead be a sign that their depression is coming back, researchers said. Related Antidepressant prescriptions have increased among young French people since 2019, report finds The findings contradict another study published earlier this year that found antidepressant withdrawal symptoms were 'common, and severe and prolonged' for many patients. But Katharina Domschke, chair of the psychiatry and psychotherapy department at the University of Freiburg in Germany, said that study was 'methodologically much weaker' because it only included 310 patients and had a higher risk of bias in the results. The latest analysis is 'extremely welcome in terms of helping to destigmatise antidepressants,' added Domschke, who was not involved with the report. The study included several types of antidepressants, including agomelatine, vortioxetine, selective serotonin reuptake inhibitors (SSRIs) such as escitalopram, sertraline and paroxetine, and serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine and duloxetine. Researchers tracked the number of symptoms that people experienced on a 43-item scale, comparing those who went off antidepressants against those taking placebos, or dummy treatments. Overall, patients who stopped antidepressants experienced one extra symptom – such as nausea or vertigo – than people who stopped placebos. For example, 20 per cent of people who stopped taking venlafaxine suffered from dizziness, compared with just 1.8 per cent of those on placebos. Related Pills or paintings? Swiss town lets doctors prescribe free museum visits as art therapy Different antidepressants also came with different severity and length of symptoms. People who went off of desvenlafaxine experienced the most symptoms, while patients who stopped vortioxetine were fairly similar to those who took placebo medicines. The review has some limitations. Most of the studies followed people for up to two weeks after they stopped taking antidepressants, making it difficult to draw conclusions about long-term effects. 'We still need more data on long-term users, individual vulnerability, and best practices for discontinuation,' Dr Christiaan Vinkers, a psychiatrist and stress researcher at Amsterdam University Medical Center who was not involved with the study, said in a statement. For now, Vinkers said, "the findings promote a more balanced and science-based understanding of antidepressant discontinuation".


Bloomberg
09-07-2025
- Bloomberg
Antidepressant Pullback Symptoms Fewer Than Thought, Study Shows
Stopping antidepressants doesn't lead to as many withdrawal symptoms as previously thought, according to a new study. In a large trial examining the crucial weeks after people end treatment, scientists found that the symptoms reported after one week weren't even enough register as clinically significant. The study, published in Jama Psychiatry on Wednesday, ruled out mood change as a symptom, while dizziness was the effect most commonly reported.